Smiths closes UK plant for cheaper Mexico
This article was originally published in Clinica
Over 530 jobs will be axed at Smiths Medical's Hythe, Kent-based manufacturing facility following the company's decision to transfer production at the UK site to another Smiths plant in Mexico.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.